2023-09-21 22:48:05
Milan (ots/PRNewswire) – Industry leaders will explore the potential of AI in contrast-enhanced MRI.
Bracco Imaging SpA, a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI), have entered into a global agreement in the field of magnetic resonance imaging (MRI). This global agreement will begin primarily in the United States, where Bracco Imaging will distribute its portfolio of products and services through its subsidiary Bracco Diagnostics Inc.
Contrast-enhanced MRI involves the use of contrast agents to highlight specific tissues or abnormalities, allowing for better visualization and more detailed information. Exploring and harnessing the power of AI in this context might lead to more precise and efficient image interpretation, improved diagnostic capabilities and optimized patient care. This strategic partnership allows Bracco Imaging and Subtle Medical to leverage each other’s intellectual property to make progress toward these ambitious goals.
Fulvio Renoldi Bracco, Vice Chairman and Managing Director of Bracco Imaging SpA, commented: “The combination of Bracco’s expertise in contrast imaging and Subtle Medical’s deep learning technology applied to MRI imaging will undoubtedly benefit physicians and their patients. Through this partnership, we will strive to redefine the boundaries of diagnostic precision and efficiency, unlocking new opportunities and creating additional value to our already unique MRI portfolio.”
“Subtle Medical is pleased to partner with a global industry leader in the development and commercialization of contrast agents like Bracco,” said Enhao Gong, CEO of Subtle Medical, Inc. “This agreement represents a significant milestone for both companies as we join forces to empower healthcare professionals and improve patient outcomes worldwide with Subtle Medical’s platform and innovative range of AI products for MRI and beyond.”
About Bracco Imaging
Bracco Imaging SpA, part of the Bracco Group, is a global leader in diagnostic imaging. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging products and solutions. The company offers a product and solution portfolio for all major diagnostic imaging technologies: X-ray imaging (including computed tomography CT, interventional radiology and cardiac catheterization), magnetic resonance imaging (MRI), contrast-enhanced ultrasound (CEUS), and nuclear medicine using radioactive markers and novel PET imaging agents to support it the clinical treatment and care of cancer patients in areas of unmet medical need. Our constantly evolving portfolio is complemented by a variety of medical devices, advanced management systems and dose management software. In 2019, Bracco Imaging expanded its product portfolio by expanding its range of nuclear medicine imaging solutions in urology and other specialties through the acquisition of Blue Earth Diagnostics. In 2021, Bracco Imaging founded Blue Earth Therapeutics as a standalone, leading biotechnology company dedicated to advancing next-generation targeted radiotherapeutics to treat cancer patients.
Further information can be found at www.bracco.com.
Information regarding Subtle Medical
Subtle Medical is a leading global provider of AI-powered technology for faster, safer and smarter medical imaging. It has been recognized as a CB Insights GenAI 50 company and has twice been recognized as one of CB Insights’ Top AI 100 and Digital Health 150 companies. The company’s innovative solutions optimize imaging processes and increase productivity and patient satisfaction. Subtle Medical is committed to using artificial intelligence to revolutionize medical imaging and shape the future of healthcare. For more information, visit subtlemedical.com or email us at the following email address: sales@subtlemedical.com.
Questions & Contact:
Media contact:
:
Micaela Colamasi
Bracco Imaging PR Manager in Micaela.Colamasi@bracco.com
+39 3482314362
Anna Menyhart-Borroni
Marketing Manager
Subtle Medical
+1 501-766-2662 anna@subtlemedical.com
Logo –
View original content:
1695341017
#BRACCO #IMAGING #SpA #ANNOUNCES #GLOBAL #AGREEMENT #SUBTLE #MEDICAL
